![Karen Ferrante](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Ferrante
Directeur/Membre du Conseil chez
MACROGENICS, INC.
Fortune : 61 360 $ au 31/05/2026
Profil
Karen Jean Ferrante is currently an Independent Director at Cogent Biosciences, Inc. since 2018, an Independent Director at MacroGenics, Inc. since 2017, and a Director at New England Women In Science Executives Club.
Former roles include Associate Director at Bristol Myers Squibb Co., Independent Director at Progenics Pharmaceuticals, Inc. from 2014 to 2020, Independent Non-Executive Director at HUTCHMED (China) Ltd. from 2017 to 2023, Independent Director at Baxalta, Inc. from 2015 to 2016, Vice President-Oncology Development at Pfizer Inc. from 1999 to 2007, Head-Oncology Therapeutic Area at Millennium Pharmaceuticals, Inc. in 2013, Chief Medical Officer at Takeda Pharmaceutical Co., Ltd. from 2007 to 2013, Chief Medical Officer and Head-Research & Technology at Tokai Pharmaceuticals, Inc. from 2014 to 2016, and Vice President-Oncology Department at Pfizer (St. Louis).
Education includes undergraduate studies at Providence College and a doctorate from Georgetown University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MACROGENICS, INC. 0,02 % | 19/05/2026 | 14 750 ( 0,02 % ) | 61 360 $ | 31/05/2026 |
| 13/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Karen Ferrante
| Sociétés | Poste | Début |
|---|---|---|
| MACROGENICS, INC. | Directeur/Membre du Conseil | 25/01/2017 |
| COGENT BIOSCIENCES, INC. | Directeur/Membre du Conseil | 01/02/2018 |
New England Women In Science Executives Club
 New England Women In Science Executives Club Miscellaneous Commercial ServicesCommercial Services Operates as a women's club which allows members to discuss their challenges, solutions and ideas | Directeur/Membre du Conseil | - |
Anciens postes connus de Karen Ferrante
| Sociétés | Poste | Fin |
|---|---|---|
| HUTCHMED (CHINA) LIMITED | Directeur/Membre du Conseil | 12/05/2023 |
| PROGENICS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 19/06/2020 |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel proprietary therapies for the treatment of prostate cancer and other hormonally driven diseases | Directeur Technique/Scientifique/R&D | 31/08/2016 |
| BAXALTA INC | Directeur/Membre du Conseil | 03/06/2016 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Directeur Technique/Scientifique/R&D | 01/05/2013 |
Formation de Karen Ferrante
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
HUTCHMED (China) Ltd.
 HUTCHMED (China) Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products | Health Technology |
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
Providence College
 Providence College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel proprietary therapies for the treatment of prostate cancer and other hormonally driven diseases | Health Technology |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
New England Women In Science Executives Club
New England Women In Science Executives Club Miscellaneous Commercial ServicesCommercial Services Operates as a women's club which allows members to discuss their challenges, solutions and ideas | Commercial Services |
